Preservation of Metabolic Flexibility in Skeletal Muscle by a Combined Use of n-3 PUFA and Rosiglitazone in Dietary Obese Mice

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Horakova, Olga ^a   Medrikova, Dasa ^a   van Schothorst, Evert M ^b   Bunschoten, Annelies ^b   Flachs, Pavel ^a   Kus, Vladimir ^a   Kuda, Ondrej ^a   Bardova, Kristina ^a   Janovska, Petra ^a   Hensler, Michal ^a   Rossmeisl, Martin ^a   Wang Sattler, Rui ^c   Prehn, Cornelia ^c   Adamski, Jerzy ^c   Illig, Thomas ^c,d   Keijer, Jaap ^b   Kopecky, Jan ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCARNITINE; CYTOCHROME P450 1A1; OMEGA 3 FATTY ACID; ROSIGLITAZONE;

ADD ON THERAPY; AMINO ACID METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG POTENTIATION; FATTY ACID OXIDATION; GENE EXPRESSION; INSULIN SENSITIVITY; JOINT MOBILITY; LIPID DIET; LOW DRUG DOSE; LUNG GAS EXCHANGE; MALE; METABOLOMICS; MOUSE; MUSCLE CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXYGEN CONSUMPTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE;

ANIMALS; DIET, HIGH-FAT; DRUG SYNERGISM; FATTY ACIDS, OMEGA-3; GENE EXPRESSION REGULATION; GLYCOLYSIS; MALE; METABOLOMICS; MICE; MICE, INBRED C57BL; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; OBESITY; OXIDATION-REDUCTION; THIAZOLIDINEDIONES;

MUS; ZEA MAYS;

EID: 84865646777     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043764     Document Type: Article

References (76)

1. Bays HE, Maki KC, McKenney J, Snipes R, Meadowcroft A, et al. (2010) Long-term up to 24-month efficacy and safety of concomitant prescription omega-3-acid ethyl esters and simvastatin in hypertriglyceridemic patients. Curr Med Res Opin 26: 907-915.
2. Reyes-Soffer G, Rondon-Clavo C, Ginsberg HN, (2011) Combination therapy with statin and fibrate in patients with dyslipidemia associated with insulin resistance, metabolic syndrome and type 2 diabetes mellitus. Expert Opin Pharmacother 12: 1429-1438.
3. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, et al. (2008) Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones. Diabetologia 51: 8-11.
4. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, et al. (2007) Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369: 1090-1098.
5. Edelstein SL, Knowler WC, Bain RP, Andres R, Barrett-Connor EL, et al. (1997) Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 46: 701-710.
6. MacLean CH, Mojica WA, Morton SC, Pencharz J, Hasenfeld Garland R, et al. (2004) Effects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythrematosus, and osteoporosis. Summary, Evidence Report. AHRQ Publication No.04-E012-1.
7. Nettleton JA, Katz R, (2005) n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review. J Am Diet Assoc 105: 428-440.
8. Kromhout D, Geleijnse JM, de Goede J, Oude Griep LM, Mulder BJ, et al. (2011) n-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in postmyocardial infarction patients with diabetes. Diabetes Care 34: 2515-2520.
9. Ruxton CH, Reed SC, Simpson MJ, Millington KJ, (2007) The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence. J Hum Nutr Diet 17: 449-459.
10. Flachs P, Rossmeisl M, Bryhn M, Kopecky J, (2009) Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. Clinical Sciences 116: 1-16.
11. Ikemoto S, Takahashi M, Tsunoda N, Maruyama K, Itakura H, et al. (1996) High-fat diet-induced hyperglycemia and obesity in mice: Differential effects of dietary oils. Metabolism 45: 1539-1546.
12. Ruzickova J, Rossmeisl M, Prazak T, Flachs P, Sponarova J, et al. (2004) Omega-3 PUFA of marine origin limit diet-induced obesity in mice by reducing cellularity of adipose tissue. Lipids 39: 1177-1185.
13. Flachs P, Horakova O, Brauner P, Rossmeisl M, Pecina P, et al. (2005) Polyunsaturated fatty acids of marine origin upregulate mitochondrial biogenesis and induce beta-oxidation in white fat. Diabetologia 48: 2365-2375.
14. Kuda O, Jelenik T, Jilkova Z, Flachs P, Rossmeisl M, et al. (2009) n-3 Fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet. Diabetologia 52: 941-951.
15. Sato A, Kawano H, Notsu T, Ohta M, Nakakuki M, et al. (2010) Antiobesity effect of eicosapentaenoic acid in high-fat/high-sucrose diet-induced obesity: importance of hepatic lipogenesis. Diabetes 59: 2495-2504.
16. Hill JO, Peters JC, Lin D, Yakubu F, Greene H, et al. (1993) Lipid accumulation and body fat distribution is influenced by type of dietary fat fed to rats. Int J Obes Relat Metab Disord 17: 223-236.
17. Belzung F, Raclot T, Groscolas R, (1993) Fish oil n-3 fatty acids selectively limit the hypertrophy of abdominal fat depots in growing rats fed high-fat diets. Am J Physiol 264: R1111-R1118.
18. Raclot T, Groscolas R, Langin D, Ferre P, (1997) Site-specific regulation of gene expression by n-3 polyunsaturated fatty acids in rat white adipose tissues. J Lipid Res 38: 1963-1972.
19. Flachs P, Ruhl R, Hensler M, Janovska P, Zouhar P, et al. (2011) Synergistic induction of lipid catabolism and anti-inflammatory lipids in white fat of dietary obese mice in response to calorie restriction and n-3 fatty acids. Diabetologia 54: 2626-2638.
20. Hensler M, Bardova K, Jilkova ZM, Wahli W, Meztger D, et al. (2011) The inhibition of fat cell proliferation by n-3 fatty acids in dietary obese mice. Lipids Health Dis 10: 128.
21. Jelenik T, Rossmeisl M, Kuda O, Jilkova ZM, Medrikova D, et al. (2010) AMP-activated protein kinase {alpha}2 subunit is required for the preservation of hepatic insulin sensitivity by n-3 polyunsaturated fatty acids. Diabetes 59: 2737-2746.
22. van Schothorst EM, Flachs P, Franssen-van Hal NL, Kuda O, Bunschoten A, et al. (2009) Induction of lipid oxidation by polyunsaturated fatty acids of marine origin in small intestine of mice fed a high-fat diet. BMC Genomics 10: 110.
23. Mori TA, Bao DQ, Burke V, Puddey IB, Watts GF, et al. (1999) Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects. Am J Clin Nutr 70: 817-825.
24. Couet C, Delarue J, Ritz P, Antoine JM, Lamisse F, (1997) Effect of dietary fish oil on body fat mass and basal fat oxidation in healthy adults. Int J Obes 21: 637-643.
25. Kunesova M, Braunerova R, Hlavaty P, Tvrzicka E, Stankova B, et al. (2006) The influence of n-3 polyunsaturated fatty acids and very low calorie diet during a short-term weight reducing regimen on weight loss and serum fatty acid composition in severely obese women. Physiol Res 55: 63-72.
26. Thorsdottir I, Tomasson H, Gunnarsdottir I, Gisladottir E, Kiely M, et al. (2007) Randomized trial of weight-loss-diets for young adults varying in fish and fish oil content. Int J Obes (Lond) 31: 1560-1566.
27. Krebs JD, Browning LM, McLean NK, Rothwell JL, Mishra GD, et al. (2006) Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women. Int J Obes (Lond) 30: 1535-1544.
28. Munro IA, Garg ML (2012) Dietary supplementation with n-3 PUFA does not promote weight loss when combined with a very-low-energy diet. Br J Nutr 1-9.
29. Storlien LH, Kraegen EW, Chisholm DJ, Ford GL, Bruce DG, et al. (1987) Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 237: 885-888.
30. Neschen S, Morino K, Dong J, Wang-Fischer Y, Cline GW, et al. (2007) n-3 fatty acids preserve insulin sensitivity in vivo in a PPAR{alpha}-dependent manner. Diabetes 56: 1034-1041.
31. Jucker BM, Cline GW, Barucci N, Shulman GI, (1999) Differential effects of safflower oil versus fish oil feeding on insulin-stimulated glycogen synthesis, glycolysis, and pyruvate dehydrogenase flux in skeletal muscle: a 13C nuclear magnetic resonance study. Diabetes 48: 134-140.
32. Kus V, Flachs P, Kuda O, Bardova K, Janovska P, et al. (2011) Unmasking differential effects of rosiglitazone and pioglitazone in the combination treatment with n-3 fatty acids in mice fed a high-fat diet. Plos One 6: e27126.
33. Fasching P, Ratheiser K, Waldhausl W, Rohac M, Osterrode W, et al. (1991) Metabolic effects of fish-oil supplementation in patients with impaired glucose tolerance. Diabetes 40: 583-589.
34. Pelikanova T, Kohout M, Valek J, Kazdova L, Base J, (1993) Metabolic effects of omega-3 fatty acids in type 2 (non-insulin-dependent) diabetic patients. Ann N Y Acad Sci 683: 272-278.
35. Kelley DE, Mandarino LJ, (2000) Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 49: 677-683.
36. Galgani JE, Moro C, Ravussin E, (2008) Metabolic flexibility and insulin resistance. Am J Physiol Endocrinol Metab 295: E1009-E1017.
37. Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, et al. (2008) Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 7: 45-56.
38. Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, et al. (2009) A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9: 311-326.
39. Newgard CB, (2012) Interplay between Lipids and Branched-Chain Amino Acids in Development of Insulin Resistance. Cell Metab 15: 606-614.
40. Punthakee Z, Bosch J, Dagenais G, Diaz R, Holman R, et al. (2012) Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial. Diabetologia 55: 36-45.
41. Kus V, Prazak T, Brauner P, Hensler M, Kuda O, et al. (2008) Induction of muscle thermogenesis by high-fat diet in mice: association with obesity-resistance. Am J Physiol Endocrinol Metab 295: E356-E367.
42. Mihalik SJ, Goodpaster BH, Kelley DE, Chace DH, Vockley J, et al. (2010) Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity. Obesity (Silver Spring) 18: 1695-1700.
43. Kwon HS, Harris RA, (2004) Mechanisms responsible for regulation of pyruvate dehydrogenase kinase 4 gene expression. Adv Enzyme Regul 44: 109-121.
44. Tillmann H, Stein S, Liehr T, Eschrich K, (2000) Structure and chromosomal localization of the human and mouse muscle fructose-1,6-bisphosphatase genes. Gene 247: 241-253.
45. James DE, Brown R, Navarro J, Pilch PF, (1988) Insulin-regulatable tissues express a unique insulin-sensitive glucose transport protein. Nature 333: 183-185.
46. Hunt MC, Rautanen A, Westin MA, Svensson LT, Alexson SE, (2006) Analysis of the mouse and human acyl-CoA thioesterase (ACOT) gene clusters shows that convergent, functional evolution results in a reduced number of human peroxisomal ACOTs. FASEB J 20: 1855-1864.
47. McGarry JD, Mills SE, Long CS, Foster DW, (1983) Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat. Biochem J 214: 21-28.
48. Todd MK, Watt MJ, Le J, Hevener AL, Turcotte LP, (2007) Thiazolidinediones enhance skeletal muscle triacylglycerol synthesis while protecting against fatty acid-induced inflammation and insulin resistance. Am J Physiol Endocrinol Metab 292: E485-E493.
49. Schiaffino S, (2010) Fibre types in skeletal muscle: a personal account. Acta Physiol (Oxf) 199: 451-463.
50. Kischel P, Bastide B, Stevens L, Mounier Y, (2001) Expression and functional behavior of troponin C in soleus muscle fibers of rat after hindlimb unloading. J Appl Physiol 90: 1095-1101.
51. Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, et al. (2002) Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418: 797-801.
52. Russell AP, Feilchenfeldt J, Schreiber S, Praz M, Crettenand A, et al. (2003) Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-gamma coactivator-1 and peroxisome proliferator-activated receptor-alpha in skeletal muscle. Diabetes 52: 2874-2881.
53. Arnold C, Konkel A, Fischer R, Schunck W-H, (2010) Cytochrome P-450-dependent metabolism of omega 6 and omega-3 long-chain polyunsaturated fatty acids. Pharmacological Reports 62: 536-547.
54. Corpeleijn E, Mensink M, Kooi ME, Roekaerts PM, Saris WH, et al. (2008) Impaired skeletal muscle substrate oxidation in glucose-intolerant men improves after weight loss. Obesity (Silver Spring) 16: 1025-1032.
55. Rustan AC, Hustvedt BE, Drevon CA, (1993) Dietary supplementation of very long-chain n-3 fatty acids decreases whole body lipid utilization in the rat. J Lipid Res 34: 1299-1309.
56. Asterholm IW, Scherer PE, (2010) Enhanced metabolic flexibility associated with elevated adiponectin levels. Am J Pathol 176: 1364-1376.
57. Hsiao G, Chapman J, Ofrecio JM, Wilkes J, Resnik JL, et al. (2011) Multi-tissue, selective PPARgamma modulation of insulin sensitivity and metabolic pathways in obese rats. Am J Physiol Endocrinol Metab 300: E164-E174.
58. An J, Muoio DM, Shiota M, Fujimoto Y, Cline GW, et al. (2004) Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. Nat Med 10: 268-274.
59. Adams SH, (2011) Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state. Advances in Nutrition 2: 445-456.
60. Gall WE, Beebe K, Lawton KA, Adam KP, Mitchell MW, et al. (2010) alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS ONE 5: e10883.
61. Lee YS, Li P, Huh JY, Hwang IJ, Lu M, et al. (2011) Inflammation is necessary for long-term but not short-term high-fat diet-induced insulin resistance. Diabetes 60: 2474-2483.
62. Varma V, Yao-Borengasser A, Rasouli N, Nolen GT, Phanavanh B, et al. (2009) Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action. Am J Physiol Endocrinol Metab 296: E1300-E1310.
63. Han MS, Lim YM, Quan W, Kim JR, Chung KW, et al. (2011) Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance. J Lipid Res 52: 1234-1246.
64. Illig T, Gieger C, Zhai G, Romisch-Margl W, Wang-Sattler R, et al. (2010) A genome-wide perspective of genetic variation in human metabolism. Nat Genet 42: 137-141.
65. Blachnio-Zabielska A, Zabielski P, Baranowski M, Gorski J, (2011) Aerobic training in rats increases skeletal muscle sphingomyelinase and serine palmitoyltransferase activity, while decreasing ceramidase activity. Lipids 46: 229-238.
66. Baranowski M, Blachnio A, Zabielski P, Gorski J, (2007) Pioglitazone induces de novo ceramide synthesis in the rat heart. Prostaglandins Other Lipid Mediat 83: 99-111.
67. Holland WL, Miller RA, Wang ZV, Sun K, Barth BM, et al. (2011) Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med 17: 55-63.
68. Coen PM, Dube JJ, Amati F, Stefanovic-Racic M, Ferrell RE, et al. (2010) Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide content. Diabetes 59: 80-88.
69. Schmitz-Peiffer C, Biden TJ, (2008) Protein kinase C function in muscle, liver, and beta-cells and its therapeutic implications for type 2 diabetes. Diabetes 57: 1774-1783.
70. Samuel VT, Shulman GI, (2012) Mechanisms for insulin resistance: common threads and missing links. Cell 148: 852-871.
71. Szendroedi J, Roden M, (2008) Mitochondrial fitness and insulin sensitivity in humans. Diabetologia 51: 2155-2167.
72. Essen B, Jansson E, Henriksson J, Taylor AW, Saltin B, (1975) Metabolic characteristics of fibre types in human skeletal muscle. Acta Physiol Scand 95: 153-165.
73. Kim HG, Han EH, Jeong HG, (2008) Effect of troglitazone on CYP1A1 induction. Toxicology 246: 166-171.
74. Zhou GD, Zhu H, Phillips TD, Wang J, Wang SZ, et al. (2011) Effects of Dietary Fish Oil on the Depletion of Carcinogenic PAH-DNA Adduct Levels in the Liver of B6C3F1 Mouse. Plos One 6: e26589.
75. Romisch-Margl W, Prehn C, Bogumil R, Rohring C, Suhre K, et al. (2012) Procedure for tissue sample preparation and metabolite extraction for high-troughput targeted metabolomics. Metabolomics 8: 133-142.
76. van Helden YG, Godschalk RW, Heil SG, Bunschoten A, Hessel S, et al. (2010) Downregulation of Fzd6 and Cthrc1 and upregulation of olfactory receptors and protocadherins by dietary beta-carotene in lungs of Bcmo1-/- mice. Carcinogenesis 31: 1329-1337.